↓ Skip to main content

Irinotecan plus S-1 versus S-1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open-labeled phase 3 trial

Overview of attention for article published in Cancer Communications, April 2019
Altmetric Badge

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
45 Mendeley